The cure rate of treating "M3 type" leukemia without bone marrow transplantation can reach 90%

• by EVOMT
• 2017-06-05

　　When it comes to leukemia, many people feel panic. In fact, leukemia is no longer a fatal disease. As long as it is detected in a timely manner and treated correctly, the survival rate of patients can be significantly improved. Among them, acute myeloid leukemia type M3 (acute promyelocytic leukemia) is currently considered to have the highest cure rate in medicine, and does not require bone marrow transplantation. This is the only disease in all leukemias that can be completely eradicated without bone marrow transplantation..

　　In an interview, Aiwo health experts pointed out that the disease is dangerous, but it is the most effective type of leukemia. If the patient receives timely treatment, the cure rate can reach over 90%. Acute myeloid leukemia M3 is a malignant disease of hematopoietic tissue that is prone to occur in young and middle-aged populations. The etiology is currently not fully understood. It is believed in medicine that the main predisposing factors include radiation pollution, chemical pollution, or drug contamination in daily life. Ivo found that the disease is a common type of acute leukemia. According to epidemiological survey, patients are mainly concentrated in young and middle-aged groups. The incidence rate of China is about 10% higher than that of western countries. Doctors have pointed out that the onset of acute myeloid leukemia M3 is dangerous. If not treated promptly and actively, the mortality rate is extremely high, and most deaths occur within 3 to 4 months of the onset. The clinical manifestations of this disease are similar to those of other acute leukemia, often manifested as recurrent fever, anemia, bleeding, lymphadenopathy, bone pain, and so on. Among them, bleeding is the greatest risk of the disease. Generally, patients will experience systemic bleeding within two weeks of onset, and 10% to 20% of patients will die of early severe bleeding. Common complications of the disease include diffuse intravascular coagulation (DIC), severe bleeding, infection, and retinoic acid syndrome. Early rapid diagnosis and cure rate Gao Aiwo pointed out that if a patient has acute myeloid leukemia type M3, it is a fortunate misfortune, because this is the type of leukemia with the highest cure rate. At the end of the last century, domestic research began to use arsenic and retinoic acid in combination with chemotherapy to treat this disease; With this standard treatment, the disease free survival rate (i.e., the proportion of patients who survive without leukemia) reaches over 90%& rdquo; The first patient to be diagnosed with this disease in 1996 has now lived to the age of 60. Aiwo emphasizes that early and rapid diagnosis is a prerequisite for patients. If patients experience symptoms such as DIC and severe bleeding, the probability of successful treatment is very low. It is recommended that once symptoms such as recurrent high fever, lymphadenopathy, periodontal bleeding, and no traumatic bone pain occur, you should go to a specialist clinic to have your blood routine checked. If your blood routine is abnormal, you should undergo bone biopsy for further elimination. Ivo pointed out that if the first induction chemotherapy can be smoothly passed, then the subsequent consolidation chemotherapy is very safe, without transplantation. Only through chemotherapy and induction differentiation treatment can achieve a 90% cure rate.